Search Results

September 2022 GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response a potential correlation between G-protein-coupled receptor-associated sorting protein 1 (GASP1) and breast However, its biological function and underlying molecular mechanism in breast cancer have not been clearly Here, we demonstrated that GASP1 was highly expressed in breast cancers, and patients harboring altered Functional studies showed that GASP1 knockout significantly suppressed malignant properties of breast

(Nasdaq: CRNX), announced that results from the company’s Phase 1 study of CRN04894, the company’s investigational

September 2022 High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes "Triple-negative breast cancer (TNBC) is a particularly aggressive It is generally considered that TNBC is an estrogen-independent breast cancer, while a new estrogen receptor These results may supply new insights into GPER-mediated estrogen carcinogenesis in TNBC, thus providing

Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain Management About Émile Breault "Emile Breault is undertaking his master's degree in pharmacology at the university of Sherbrooke Émile Breault on the web Google Scholar ResearchGate Dr.

Download PDF Program HERE < Back to Full Agenda Posters Interrogating The Role Of CELSR1 (ADGRC1) In Breast Cancer Caroline Formstone Abstract "Breast cancer is the most common form of cancer amongst women. Recent studies identify CELSR1, a key PCP gene, as a novel biomarker for early-stage breast cancer. Notably, our pilot data from luminal-type breast cancer cell lines representative of breast carcinomas isoforms differentially influence the stability of cell-cell and/or cell-matrix adhesions to dictate breast

., PNAS, 2014) in breast cancer pathogenesis, using mouse models, three-dimensional cell culture and cell polarity and its role in cancer progression, his work on G-protein coupled receptors (GPCRs) in breast his initial struggles during his Ph.D., such as a difficult model system and a lack of experimental results He also discussed his work on G-protein coupled receptors (GPCRs) in breast cancer, identifying GPR161 as a potential drug target due to its high expression in triple negative breast cancer.